Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

NCT00143741 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00143741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2005
Completion date
July 31, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage kidney disease